These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12873865)

  • 21. Donepezil improves symptoms of delirium in dementia: implications for future research.
    Wengel SP; Roccaforte WH; Burke WJ
    J Geriatr Psychiatry Neurol; 1998; 11(3):159-61. PubMed ID: 9894735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting cognitive decline in Alzheimer's disease: an integrated analysis.
    Lopez OL; Schwam E; Cummings J; Gauthier S; Jones R; Wilkinson D; Waldemar G; Zhang R; Schindler R
    Alzheimers Dement; 2010 Nov; 6(6):431-9. PubMed ID: 21044773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dementia and/or depression].
    Nicoulaud L; Gallarda T
    Encephale; 2005 Oct; 31 Pt 2():S56-8. PubMed ID: 16673711
    [No Abstract]   [Full Text] [Related]  

  • 24. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease.
    Falk WE; Daly EJ; Tsai GE; Gunther J; Brown P
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):466-7. PubMed ID: 12426422
    [No Abstract]   [Full Text] [Related]  

  • 25. Is donepezil useful for improving cognitive dysfunction in bipolar disorder?
    Kelly T
    J Affect Disord; 2008 Apr; 107(1-3):237-40. PubMed ID: 17825922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

  • 27. Mild cognitive impairment: a treatment at last?
    Allain H; Bentué-Ferrer D; Akwa Y
    Lancet Neurol; 2004 Nov; 3(11):643. PubMed ID: 15488455
    [No Abstract]   [Full Text] [Related]  

  • 28. Cognitive impairment in ICU survivors: assessment and therapy.
    Wergin R; Modrykamien A
    Cleve Clin J Med; 2012 Oct; 79(10):705-12. PubMed ID: 23027729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advertisements for donepezil. Review of drug in Drug and Therapeutics Bulletin is uninformed.
    Wilkinson D
    BMJ; 1997 Dec; 315(7122):1625. PubMed ID: 9437307
    [No Abstract]   [Full Text] [Related]  

  • 30. New therapeutic approaches to cognitive impairment.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil in vascular dementia: a viewpoint by Sandra E. Black.
    Black SE
    Drugs Aging; 2003; 20(15):1138. PubMed ID: 14651438
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients.
    Werber EA; Gandelman-Marton R; Klein C; Rabey JM
    J Neural Transm (Vienna); 2003 Jun; 110(6):659-69. PubMed ID: 12768361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donepezil significantly improves abilities in daily lives of female Down syndrome patients with severe cognitive impairment: a 24-week randomized, double-blind, placebo-controlled trial.
    Kondoh T; Kanno A; Itoh H; Nakashima M; Honda R; Kojima M; Noguchi M; Nakane H; Nozaki H; Sasaki H; Nagai T; Kosaki R; Kakee N; Okuyama T; Fukuda M; Ikeda M; Shibata Y; Moriuchi H
    Int J Psychiatry Med; 2011; 41(1):71-89. PubMed ID: 21495523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
    Dubois B; Tolosa E; Katzenschlager R; Emre M; Lees AJ; Schumann G; Pourcher E; Gray J; Thomas G; Swartz J; Hsu T; Moline ML
    Mov Disord; 2012 Sep; 27(10):1230-8. PubMed ID: 22915447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating visual hallucinations with donepezil.
    Burke WJ; Roccaforte WH; Wengel SP
    Am J Psychiatry; 1999 Jul; 156(7):1117-8. PubMed ID: 10401470
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.